Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Colorectal Neoplasms 2Breast Neoplasms 2Stress Disorders, Post-Traumatic 1Sleep Wake Disorders 1Prostatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Leukemia 1Fatigue 1Depression 1Colonic Neoplasms 1Cardiotoxicity 1Anxiety Disorders 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Exercise Test × Clear all
NCT01186367 2025-02-10

Excite

Memorial Sloan Kettering Cancer Center

Phase NA Completed
174 enrolled 11 charts
Breast

Breast Neoplasms

NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Wake Forest University Health Sciences

Phase NA Completed
28 enrolled 17 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡